Archived Newsletters

  1. 04.20.17 -- Early Development Strategies For First-In-Human
    4/20/2017
    04/20/17 Outsourced Pharma Newsletter
  2. 04.19.17 -- It Could Be At Takeda Or P&G: The Three Pieces of Outsourcing
    4/19/2017
    04/19/17 Outsourced Pharma Newsletter
  3. 04.12.17 -- Is Your Outsourcing Reliable, Responsive, And Continuously Compliant?
    4/12/2017
    04/12/17 Outsourced Pharma Newsletter
  4. 04.05.17 -- M&A Crucible in Contract Drug Development And Manufacturing
    4/5/2017
    04/05/17 Outsourced Pharma Newsletter
  5. 03.29.17 -- The Three Pillars Of Industry Conferences
    3/29/2017
    03/29/17 Outsourced Pharma Newsletter
  6. 03.23.17 -- Insource vs. Outsource -- Everything You Need To Know
    3/23/2017
    03/23/17 Outsourced Pharma Newsletter
  7. 03.22.17 -- Adversity On The Path To Global Drug Distribution
    3/22/2017
    03/22/17 Outsourced Pharma Newsletter
  8. 03.15.17 -- High Potency Service Providers: The Contenders And Pretenders
    3/15/2017
    03/15/17 Outsourced Pharma Newsletter
  9. 03.08.17 -- The "Isle Of Difference" In Contract Development And Manufacturing
    3/8/2017
    03/08/17 Outsourced Pharma Newsletter
  10. 03.06.17 -- Modular Bioprocess Platform Gives CMO Maximum Flexibility
    3/6/2017
    03/06/17 Outsourced Pharma Newsletter